Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 regarding investment in different segments.

Date: August 08, 2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Name: AMWILL HEALTH CARE LIMITED. Company Scrip Code.: 544353 Re: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ("SEBI Listing Regulations") read with SEBI Master Circular no. (Ref: HO/49/14/14(7)2025-CFD- POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”). Subject: Intimation of Approval of Investment Limits Across Different Segments as Detailed Below. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the Investment Committee, at its meeting held on today, August 08, 2026 has approved the following investments from the Company’s internal accruals. As part of our commitment to prudent balance sheet management, we are introducing a hybrid treasury strategy to optimize our surplus cash. While the primary base of our liquid reserves will continue to remain safely anchored in traditional Bank Fixed Deposits for absolute safety and operational liquidity, we are allocating a defined, measured portion of surplus capital into an active multi-asset framework. This balanced approach ensures we maintain complete safety while capturing higher post-tax, risk-adjusted returns on our excess capital. 1) Investment in Government Securities (G-Secs), Treasury Bills, Government Bonds, Non- Convertible Debentures (NCDs), Commercial Papers and Other Debt Securities up to an Aggregate Limit of ₹10,00,00,000 (Rupees Ten Crore Only). 2) Investment of surplus funds in listed equity shares and subscription to Mainboard and SME Initial Public Offers (IPOs) up to an aggregate limit of ₹2,00,00,000 (Rupees Two Crore Only). 3) Investments in Private Credit Funds, Alternative Investment Funds (AIFs), Structured Debt Instruments, and other debt-oriented investment opportunities, from time to time, up to an aggregate investment limit of ₹15,00,00,000 (Rupees Fifteen Crore Only). 4) Investment of surplus funds in invoice discounting platforms and other investment opportunities, including long-term and short-term bonds shall not exceed INR 3,00,00,000 (Indian Rupees Three Crore Only). 5) Investment of surplus funds through Systematic Investment Plans (SIPs) in Mutual Funds (Equity and Debt-Oriented Schemes) and Mutual Funds, subject to an overall cumulative investment ceiling of INR 3,00,00,000 (Indian Rupees Three Crore Only). The investment does not involve any related party transaction. This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is submitted for your information and record, will be available on the website of the Company www.amwillhealthcare.com. Thanking You. FOR AMWILL HEALTH CARE LIMITED Anshu Anshuman Company secretary and compliance Officer ACS65515